The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.093%)
Open: 147.75
High: 147.75
Low: 147.75
Prev. Close: 147.75
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement on the Outcome of 2018 BoE Stress Test

28 Nov 2018 17:44

RNS Number : 8278I
Santander UK Group Holdings PLC
28 November 2018
 

28 November 2018

 

SANTANDER UK GROUP HOLDINGS PLC

 

STATEMENT ON THE OUTCOME OF THE 2018 BANK OF ENGLAND STRESS TESTS

 

Santander UK notes the publication of the results of the 2018 stress tests conducted on seven major UK banks and building societies by the Bank of England.

 

As a result of the exercise, the Bank of England does not require Santander UK to undertake any actions.

 

Since the introduction of IFRS 9 in January 2018 the stress test results are published on an IFRS 9 transitional and non-transitional basis, over a five-year stress period to the end of 2022.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress CRD IV end-point common equity tier 1 ('CET 1') capital ratio was modelled to be 10.8% before management actions and 10.9% after allowed management actions.

 

On an IFRS 9 non-transitional basis Santander UK's lowest post-stress CRD IV end-point CET 1 capital ratio, was modelled to be 9.5% before management actions and 9.7% after allowed management actions.

 

These results are significantly in excess of the CET 1 hurdle rate established by the Bank of England of 7.5% on an IFRS 9 transitional basis, and 7.7% on an IFRS 9 non-transitional basis.

 

Santander UK reported a CET 1 capital ratio of 13.1% as at 30 September 2018.

 

For the third year in a row, Santander UK had the lowest stressed CET1 ratio impact of all participating firms, demonstrating our resilient balance sheet and prudent approach to risk.

 

The Bank of England's CET1 hurdle rate comprises the CRR Pillar 1 minimum of 4.5% together with a Pillar 2A CET1 requirement, an estimate of the applicable Systemic Risk Buffer and an adjustment to offset the pro-cyclical impacts of IFRS 9. Santander UK expects that a Pillar 2A requirement of 3.1% and Systemic Risk Buffer will be set in the first quarter of 2019.

 

On an IFRS 9 transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2022, was modelled to be 3.9% both before and after management actions.

 

On an IFRS 9 non-transitional basis Santander UK's lowest post-stress end-point leverage ratio, over a five-year stress period to the end of 2022, was modelled to be 3.4% both before and after management actions.

 

These results are in excess of the leverage threshold established by the Bank of England of 3.26% on an IFRS 9 transitional and 3.25% on an IFRS 9 non-transitional basis. Santander UK reported a leverage ratio of 4.4% as at 30 September 2018, consistent with the ratio as at 31 December 2017. As at 30 September 2018 the leverage exposure was £279bn. 

Disclaimer

Santander UK Group Holdings plc and Banco Santander, S.A. both caution that this announcement may contain forward-looking statements. Such forward-looking statements are found in various places throughout this announcement. Words such as "believes", "anticipates", "expects", "intends", "aims" and "plans" and other similar expressions are intended to identify forward-looking statements, but they are not the exclusive means of identifying such statements. Forward-looking statements include, without limitation, statements concerning our future business development and economic performance. These forward-looking statements are based on management's current expectations, estimates and projections and both Santander UK Group Holdings plc and Banco Santander, S.A. caution that these statements are not guarantees of future performance. We also caution readers that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. We have identified certain of these factors in the forward looking statements on page 259 of the Santander UK Group Holdings plc 2017 Annual Report and page 72 of the Santander UK Group Holdings plc 2018 Half Yearly Financial Report. Investors and others should carefully consider the foregoing factors and other uncertainties and events. Undue reliance should not be placed on forward-looking statements when making decisions with respect to Santander UK Group Holdings plc, Santander UK plc, Banco Santander, S.A. and/or their securities. Such forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

Contacts

Bojana FlintHead of Investor Relations020 7756 6474

Andy Smith Head of Media Relations020 7756 4212

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGBWGUPRGMR
Date   Source Headline
17th Aug 20181:17 pmRNSForm 8.3 - Shire plc
17th Aug 20181:16 pmRNSForm 8.3 - Shire plc
17th Aug 20181:15 pmRNSForm 8.3 - Shire plc
14th Aug 20181:47 pmRNSPublication of Final Terms
10th Aug 20185:28 pmRNSPublication of Suppl.Prospcts
10th Aug 20187:15 amRNSHalf-year Report
10th Aug 20187:15 amRNSHalf-year Report
25th Jul 20182:24 pmRNSPublication of Suppl.Prospcts
25th Jul 20182:16 pmRNSPublication of Suppl.Prospcts
25th Jul 20187:15 amRNSQuarterly Management Statement - 30 June 2018
9th Jul 20184:24 pmRNSArticle 8
9th Jul 201812:02 pmRNSNotice of Delisting
25th Jun 201812:31 pmRNSPublication of Suppl.Prospcts
25th Jun 201812:26 pmRNSPublication of Suppl.Prospcts
13th Jun 201810:47 amRNSApproval of Ring-Fencing Transfer Scheme
31st May 201810:53 amRNSDirectorate Change
14th May 20182:24 pmRNSArticle 8
14th May 201811:29 amRNSNotice of Delisting - Series 1125
8th May 20184:21 pmRNSPublication of Final Terms
8th May 20183:26 pmRNSPublication of Final Terms
4th May 201812:41 pmRNSPublication of Final Terms
27th Apr 20184:47 pmRNSStatement re Change of Paying & Transfer Agent
27th Apr 201811:46 amRNSNotice Change of Agent
24th Apr 20186:15 pmRNSPublication of a Prospectus
24th Apr 20182:36 pmRNSPublication of Suppl.Prospcts
24th Apr 20187:15 amRNS1st Quarter Results
13th Apr 20182:16 pmRNSPublication of Final Terms
11th Apr 20184:49 pmRNSOffer period extension Series 1125-1126
29th Mar 201811:29 amRNSArticle 8
28th Mar 20185:11 pmRNSPublication of Final Terms
26th Mar 20184:27 pmRNSArticle 8
19th Mar 20182:29 pmRNSDelisting notice - Series 1121 - XS1710683985
19th Mar 201811:52 amRNSArticle 8
12th Mar 201810:40 amRNSCall notice XS0907246812. Series 790
9th Mar 20183:46 pmRNSPublication of Final Terms
2nd Mar 20184:31 pmRNSPre-Stab: Santander, GBP 50m Tap, due 27/02/2020
2nd Mar 20184:14 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:10 pmRNSPublication of Suppl.Prospcts
2nd Mar 20184:02 pmRNSPublication of Final Terms
2nd Mar 20183:58 pmRNSPublication of Final Terms
28th Feb 201812:45 pmRNSAnnual Financial Report
28th Feb 201812:40 pmRNSAnnual Financial Report
26th Feb 20185:20 pmRNSPublication of Final Terms
23rd Feb 20182:47 pmRNSArticle 8
22nd Feb 20185:34 pmRNSPre-Stab Notice - SANUK, GBP 250m, due 27/02/2020
12th Feb 201810:58 amRNSNotice of Early Redemption
7th Feb 20185:43 pmRNSPublication of Suppl.Prospcts
7th Feb 20185:39 pmRNSPublication of Suppl.Prospcts
6th Feb 201811:41 amRNSUpdate on Ring-fencing & Part VII Transfer Scheme
31st Jan 20187:15 amRNSQ4 17 - Quarterly Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.